Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
There is a widespread acceptance in the literature that plasma nonesterified fatty acids (NEFA), also called free fatty acids (FFA), can mediate many adverse metabolic effects, most notably insulin resistance. Elevated NEFA concentrations in obesity are thought to arise from an increased adipose tissue mass. It is also argued that the process of fatty acid mobilization from adipose tissue, normally suppressed by insulin, itself becomes insulin resistant—thus, lipolysis is further increased, potentially leading to a vicious cycle. Although we have also accepted this model for many years (1,2), recently there has been a steady accumulation of data, both in the literature and from our own research, that has forced us to realize that this simple story is not always true. Here we review the background to the idea of “fatty acids as metabolic villains,” together with data from the literature and from our own studies, which tend to show another side to the fatty acids/insulin resistance story. We will first examine the relationship between systemic concentrations of NEFA and obesity/insulin resistance and then study adipose tissue in the obese state with regard to its adaptation for NEFA release. NEFA circulate in the plasma bound to plasma albumin. Their function was largely elucidated in the 1950s through the work of Vincent Dole (3) at the Rockefeller Institute in New York and Robert Gordon (4,5) at the National Institutes of Health. Gordon demonstrated the origin of plasma NEFA from adipose tissue and their use by tissues such as the liver and myocardium, but not the brain. We now recognize that NEFA are the vehicle by which triacylglycerol (TG) stored in adipose tissue is transported to its sites of utilization. NEFA turnover is rapid, with a plasma half-life around 2–4 min (6). The only significant site of NEFA liberation …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The amount of liberated FFA from chylomicrons and VLDL depends on the activity of LPL, which is stimulated by insulin [17,18].”
From Dyslipidemia in obesity: Mechanisms and potential targets (2013) · cites this paper as [17]
Experimental — accuracy not yet measuredIn the citing paper
“These observations suggest that carbohydrate restriction reduces insulin secretion, which may facilitate fat mobilization (33), particularly from the intra-abdominal area, a depot associated with metabolic dysfunction that is enlarged in individuals with T2D (34,35).”
From A Lower-Carbohydrate, Higher-Fat Diet Reduces Abdominal and Intermuscular Fat and Increases Insulin Sensitivity in Adults at Risk of Type 2 Diabetes (2015) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705 · cited 1×
“With this approach, it is easy to show that elevated NEFA concentrations are associated acutely with insulin resistance, both with peripheral glucose uptake (33,34) and hepatic gluconeogenesis (35,36) and with impaired glucose tolerance (37).”
BackgroundA RELATION BETWEEN NON-ESTERIFIED FATTY ACIDS IN PLASMA AND THE METABOLISM OF GLUCOSE
Dole, V. P. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103259 · Cited by 3,454 · cited 1×
“Their function was largely elucidated in the 1950s through the work of Vincent Dole (3) at the Rockefeller Institute in New York and Robert Gordon (4,5) at the National Institutes of Health.”
BackgroundRomijn, J. A., Coyle, E. F., Sidossis, L. S., Gastaldelli, A., Horowitz, J. F., Endert, E., & Wolfe, R. R. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.3.e380 · Cited by 1,747 · cited 1×
“somewhat (2), but often plasma NEFA concentrations remain relatively stable as removal by muscle increases to match adipose tissue lipolysis (27,28).”
BackgroundLipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100 · cited 1×
“The detrimental effects on insulin sensitivity and other cellular processes are known as lipotoxicity (57).”
BackgroundSplanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933 · cited 1×
“The abdominal subcutaneous fat depot is the dominant source of NEFA; considerably less comes from leg adipose tissue and—against popular belief—only a small proportion of the systemic NEFA concentrations arises from intraabdominal adipose tissue (7).”
BackgroundLipolysis and lipid mobilization in human adipose tissue
Lafontan, M., & Langin, D. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.05.001 · Cited by 826 · cited 1×
“It has been reviewed recently (8), and we will not cover those aspects here.”
BackgroundGroop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812 · cited 2×
“The rationale for this supposition comes from the fact that adipose tissue could be seen as insulin resistant in obesity and therefore as not responding adequately to the antilipolytic action of insulin (29).”
Background
Cited by
Items 801–894 of 894
Veras, K. M. D. A. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2017.tde-07032017-111930
dos Santos, D. X. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2018.tde-22012018-101115
Kuwabara, W. M. T. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2018.tde-05022018-092852
Wang, G. (2018) · VTechWorks (Virginia Tech)
Saro, N., Hadju, V., & Wahyu, A. (2018) · International Conference on Healthcare Service Management (ICHSM) · doi:10.1145/3242789.3242813
“Differences with normal people, although not in a state of fasting, the production of NEFA obese people are not biased suppressed, this is what causes metabolic disorders [10].”
BackgroundKedyk, A. V., & Rishko, M. V. (2019) · Medical and Clinical Chemistry · doi:10.11603/mcch.2410-681x.2018.v0.i4.9829
An exploration into the proteins that regulate skeletal muscle lipid metabolism
Whytock, K. L. (2021) · Liverpool John Moores University · doi:10.24377/ljmu.t.00009962 · Cited by 2
Côté, J. A. (2013) · Corpus Université Laval (Université Laval)
Thole, S. W. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7119
“Die Obesitas-bedingte Zunahme der FFS führt zu einer gesteigerten Produktion von reaktiven Sauerstoffspezies (Furukawa et al. 2004) und ist gleichzeitig auch Folge der Insulinresistenz selbst (Karpe et al. 2011).”
BackgroundLee, S. J., & Shin, S. W. (2019) · Preprints.org · doi:10.20944/preprints201909.0247.v2
Insulin sensitivity is mediated by glucose in the hepatoportal region in the rat
Johnson, H. M. (2017) · The Sydney eScholarship Repository (The University of Sydney)
Identifying Potential biomarkers of insulin sensitivity and insulin resistance in obese patients
Al‐Sulaiti, H. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.122707627 · Cited by 1
Lou, S. (2013) · Surrey Research Insight Open Access (The University of Surrey) · Cited by 1
Sex as a modulator of lipid metabolism and metabolic disease
Vergnes, L., Riestenberg, C. K., & Reue, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00003-8
The Role of the Intestinal Immune System in Diet-induced Obesity and Insulin Resistance
Luck, H. (2020) · TSpace (University of Toronto)
Selenium Supplement for Obesity and Diabetes
Chen, D. (2020) · Interventions in Obesity & Diabetes · doi:10.31031/iod.2020.03.000574
“Also, high concentration of FFA in serum may reduce peripheral tissue sensitivity to insulin and decrease glucose uptake, triggering IR [24-26].”
BackgroundZerk eragiten du obesitatea duen pertsona bat metabolikoki osasuntsua izatea edo ez izatea?
Rodríguez, O. A., & Eseberri, I. (2021) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.22345
Impact of Maternal Inflammatory Conditions on the Expression of Drug Transporters
Ghoneim, R. H. (2016) · TSpace (University of Toronto)
Pharmacological Evaluation of GPR40 Full Agonists in Metabolic Disease Models
上野, 光., ウエノ, ヒ., & Ueno, H. (2021) · Terrestrial Environment Research Center (University of Tsukuba)
Metabolic risk factors in mothers and metabolic profile of neonates
Jing-ya, W. (2019) · University of Birmingham Institutional Research Archive (University of Birmingham)
Flores, D., Murúa, F., & Acosta, J. C. (2007) · Boletín de la SEA
Modulation of fat oxidation: nutritional and pharmacological approach
van Can, J. G. P. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20121031jc
Dietary strategies to modulate the metabolic profile and substrate partitioning
Munsters, M. J. M. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140417mm
Trim, W. V., Thompson, D., & Turner, J. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-39903-0_101903
Wang, Y. E., Kirschke, C. P., Woodhouse, L. R., Bonnel, E. L., Stephensen, C. B., Bennett, B. J., Newman, J. W. I., Keim, N. L., & Huang, L. (2020) · doi:10.21203/rs.3.rs-94525/v1
“A number of studies have suggested that reduced circulating NEFA is correlated with a lower ability to oxidize fat and subsequently liberate NEFA into plasma from adipose tissue leading to metabolic deterioration [72, 73].”
BackgroundWang, Y. E., Kirschke, C. P., Woodhouse, L. R., Bonnel, E. L., Stephensen, C. B., Bennett, B. J., Newman, J. W. I., Keim, N. L., & Huang, L. (2022) · Research Square · doi:10.21203/rs.3.rs-1019814/v1
CORRELATION BETWEEN BODY MASS INDEX AND BLOOD GLUCOSE AMONG UNDERGRADUATE STUDENTS
Arjun, R., Joy, B. E., Joy, S., Shaji, V., Vismaya, P. P., & Padmapriya, S. (2022) · Indian Journal Of Applied Research · doi:10.36106/ijar/4703948
A comprehensive dynamic model of the adipocyte
Lövfors, W. (2022) · Linköping studies in science and technology. Dissertations · doi:10.3384/9789179293130
Lee, S. J., & Shin, S. W. (2019) · Preprints.org · doi:10.20944/preprints201909.0247.v1
Lipidoma plasmático em mulheres com obesidade submetidas ao treinamento físico combinado
Santibáñez, R. P. S. M. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-08082022-112403
Fitoterapia Chinesa no tratamento complementar da Síndrome Metabólica: uma revisão sistemática
Campos, L. S., Soares, L. G., Leonel, C. F. S., da Rosa, R. D., & Byk, J. (2023) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e12022.2023
(2023) · International Journal of Diabetes & Metabolic Disorders · doi:10.33140/ijdmd.08.02.10
Carbohydrate, Protein, and Fat Metabolism in Obesity
Galgani, J. E., Cortés, V., & Carrasco, F. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_21-2
Chemical constituents of fan-si abutilon indicum stems
Widyasti, A. R. (2021) · Chula Digiverse · doi:10.58837/chula.the.2021.63
(2023) · International Journal of Diabetes & Metabolic Disorders · doi:10.33140/ijdmd.08.02.09
Caressa, D. A., Adi, A. C., Adiningsih, S. H., Purwoto, S. P., & Pranoto, A. (2022) · Indonesian Journal of Human Nutrition · doi:10.21776/ub.ijhn.2022.009.01.3
Tadesse, H., Mulat, E., Dereje, D., Berhanu, A., & Abera, M. (2024) · Research Square · doi:10.21203/rs.3.rs-3845993/v1
Analysis of Obesity Based on Various Indicators by Countries via Linear Regression
Rhee, A., & Datta, P. (2023) · Journal of Student Research · doi:10.47611/jsrhs.v12i4.5659
“Individuals who have fat accumulated towards the periphery are more insulin sensitive than those who have fat accumulated in the abdomen and chest areas (Karpe et al., 2011).”
Backgroundİnsülin 100 Yıllık Mucize Hormon
Cerit, E. T., Barlas, T., Atalar, K., Bahçelioğlu, M., Kaplanoğlu, G. T., Seymen, C. M., Erdem, H. B., Ergün, M. A., Demir, Ö., Gülbahar, Ö., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.871
Keperawatan Medikal Bedah, F. I. K., Kristianto, H., Hany, A., Keperawatan Medikal Bedah, F. I. K., Widyanto, R. M., Ilmu Gizi, F. I. K., Christina, K., Mahasiswa Sarjana Ilmu Keperawatan, F. I. K., Rieski, W. A., Mahasiswa Profesi Ners, F. I. K., et al. (2024) · Caring Jurnal Pengabdian Masyarakat · doi:10.21776/10.21776/ub.caringjpm.2024.004.01.1
Song, S., Yin, J., Liu, Y., Li, X., Li, M., Zhang, W., Liu, Y., & Yang, J. (2024) · Research Square · doi:10.21203/rs.3.rs-4792127/v1 · Cited by 1
Johnson, M. A., Priesemuth, M., & Moreno, F. J. (2024) · Human Performance · doi:10.1080/08959285.2024.2413462
“In addition, visceral fat is related to more non-esterified fatty acid production than subcutaneous fat; this fatty acid production is related to adverse metabolic effects like insulin resistance and diabetes (Karpe et al., 2011).”
Tariqa, S. Z., El-amamyb, A. B., Zakokoa, A. M., Awada, A. A., Younisa, M. Y., Benhasounac, A. A., Gehanic, K. A. E., & Elshaaria, F. A. (2024) · Libyan Journal of Science &Technology · doi:10.37376/ljst.v12i1.7065
“Thus, Karpe et al ., (2011) suggested that the link between circulating free fatty acids levels and insulin sensitivity in vivo needs further investigation to elucidate the details of such a complicated relationship.”
Novel Triazolopyrimidinone Compounds as Inhibitors of Adipocyte Fatty Acid–Binding Protein (FABP4)
Saylam, M., Köse, F. A., Çoban, G., & İstanbullu, H. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500205
Erum, M., Chaudhury, D., Ghotekar, L. H., Islam, S., & Goswami, A. (2025) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20250933
Metabolic profile of healthy, normal-weight adults with low satiety responsiveness
Oliveira, C. L. P., Elliott, S. A., Sharma, A. M., Siervo, M., Berg, A., Ghosh, S., Drapeau, V., & Prado, C. M. M. (2025) · Appetite · doi:10.1016/j.appet.2025.108031
“It has been demonstrated that males present with lower circulating total and HDL cholesterol, glycerol, and NEFA when compared with females (Karpe et al., 2011; Mittendorfer et al., 2001; Swiger et al., 2014).”
Podkuychenko, N. V., Bogdanova, P. A., Perelygina, V. S., Tikhonov, A. N., Badun, G. A., Sudnitsyna, M. V., & Vorotnikov, A. V. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.11.693656
“We treated adipocytes for 2 days with 1 mM of these FFA in their ratio to albumin of 2.7, assuming that their normal systemic levels are in the range of 0.5-0.6 mM (Arner, Ryden, 2015, Karpe et al., 2011) and there are 3 high affinity FFA binding sites in albumin (Curry 2003).”
InfluentialTan, H. Y. (2014) · The University of Queensland · doi:10.14264/uql.2015.99
Suklaew, P. O. (2014) · NRCT Data Center · doi:10.14457/cu.the.2014.89
Wang, Y. E., Kirschke, C. P., Woodhouse, L. R., Bonnel, E. L., Stephensen, C. B., Bennett, B. J., Newman, J. W., Keim, N. L., & Huang, L. (2022) · Figshare · doi:10.6084/m9.figshare.20782248
Han, Q., Wang, J., Li, W., Chen, Z.-J., & Du, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14551578
Han, Q., Wang, J., Li, W., Chen, Z.-J., & Du, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14551569
Wang, Y. E., Kirschke, C. P., Woodhouse, L. R., Bonnel, E. L., Stephensen, C. B., Bennett, B. J., Newman, J. W., Keim, N. L., & Huang, L. (2022) · Figshare · doi:10.6084/m9.figshare.20782245
Wang, Y. E., Kirschke, C. P., Woodhouse, L. R., Bonnel, E. L., Stephensen, C. B., Bennett, B. J., Newman, J. W., Keim, N. L., & Huang, L. (2022) · Figshare · doi:10.6084/m9.figshare.20782251
Han, Q., Wang, J., Li, W., Chen, Z.-J., & Du, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14551566
Han, Q., Wang, J., Li, W., Chen, Z.-J., & Du, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14551575
Han, Q., Wang, J., Li, W., Chen, Z.-J., & Du, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14551572
Wang, Y. E., Kirschke, C. P., Woodhouse, L. R., Bonnel, E. L., Stephensen, C. B., Bennett, B. J., Newman, J. W., Keim, N. L., & Huang, L. (2022) · Figshare · doi:10.6084/m9.figshare.20782242
Pathogenesis of type 2 diabetes
Honka, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00376-9
Spatial Immunological Microenvironment in Osteoarthritis
Varughese, I. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.257062
Pathophysiology, Biochemistry, and Molecular Landscape of Insulin Resistance in Type 2 Diabetes
Vorotnikov, A. V., Podkuychenko, N. V., & Shestakova, M. V. (2026) · Biochemistry (Moscow) · doi:10.1134/s0006297925604198 · Cited by 1
Mattihalli, A. K., Patil, P. S., Kavitha, C. M., & B, S. K. (2026) · International Ayurvedic Medical Journal · doi:10.46607/iamj1714012026
Liu, D., Tian, P., Hou, Y., Zhang, T., Lu, Y., Ren, L., Wang, C., & Song, G. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1760358
Caractérisation du canal cationique TRPV1 dans les cardiomyocytes
Païta, L. (2016) · theses.fr (ABES) · doi:10.70675/02a0b431zc596z49d9zac14zd2988d346012
New biomarkers and therapeutic targets in left ventricular hypertrophy
Evaristi, M. F. (2017) · theses.fr (ABES) · doi:10.70675/0d048706z75d9z4ea2za46fz8f14c110ade5
Awwad, A. (2018) · theses.fr (ABES) · doi:10.70675/27dcfcbezb2a9z4c48zb673zf60decded54f · Cited by 1
Begey, A.-L. (2018) · theses.fr (ABES) · doi:10.70675/d27994bbz9ea0z4727za8f5zbb789d22105d
Recazens, E. (2021) · theses.fr (ABES) · doi:10.70675/5b66fe82zcbbbz4251z98c0z2bb967f598c2
Role of Cell Surface Receptors in Palmitic Acid-Induced Expression of IL-1β in Microglial Cells
Jadeja, V., Ma, S., & Zhou, H. (2026) · Lipidology · doi:10.3390/lipidology3020015
“Under fasting conditions, circulating FFA concentrations in healthy individuals typically range between 100 and 400 µ M, with PA representing a substantial fraction of this pool [69].”
HealthMarkers: Clinical and Metabolic Biomarker Calculation Toolkit
Suleman, S. (2026) · CRAN: Contributed Packages · doi:10.32614/cran.package.healthmarkers
The regulation of intrahepatic fatty acid partitioning within the human liver: the effect of sex
Dennis, K. M. J. H., Start, C. A. T., Josh, D., & Hodson, L. (2026) · Clinical Science · doi:10.1042/cs20260180
“The discrepancy in findings is potentially due to the high variability observed in fasting plasma NEFA concentrations within individual participants [49,50] amplified by the relatively small sample sizes of many in vivo human studies.”
Wang, X., Zheng, W., Jin, X., Liu, H., Hao, J., Zhang, L. L., Gu, Y., Hou, H., & Wang, W. (2026) · Journal of Global Health · doi:10.7189/jogh.16.04113
“These components influence the differentiation and metabolism of adipose cells, augmenting the release of free fatty acids, thereby further exacerbating IR [ 39 – 41 ].”
Chen, J. M., He, T., Zhang, S., Zheng, X., Zhao, J., Zheng, J., & Yang, Z. (2026) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2026.112990
Calcium dysregulation in diabetic cardiomyopathy & heart failure with preserved ejection fraction
Ali, A., Sharma, V. M., & Aguilar-Sánchez, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1872513
“Redox or reactive oxygen species (ROS) modifications alter beta cell functions, which leads to hyperinsulinemia causing insulin resistance as an adaptive response to maintain normal levels of fat and glucose until beta cells become exhausted and collapse (14, 15).”
liu, L., Ren, Z., Jiang, X., deng, W., & 陈以宽 (2026) · Research Square · doi:10.21203/rs.3.rs-9819050/v1
Modelling Type 2 Diabetes: Investigating Relapse Post Remission
Sweatman, C. Z. W. H. (2026) · Springer proceedings in mathematics & statistics · doi:10.1007/978-3-032-17956-2_1
Nelluri, P. S., Nibbaragandla, R. S., Thiriveedhi, S., Lingareddy, K. R. R., Chinthakrinda, M., Nallani, S. P., Bhatti, C., & Maharjan, S. (2026) · Scientific Reports · doi:10.1038/s41598-026-72334-z
“…of reduced aspirin pharmacodynamic response, acting through accelerated platelet turnover, altered aspirin pharmacokinetics, and a chronic pro-thrombotic, inflammatory state; elevated circulating free fatty acids, characteristic of obesity and insulin resistance, contribute to this milieu 28,29 .”
Li, Y., Yin, M., Zheng, H., Tang, Z., Yan, H., Vollaard, N. B. J., & Liu, Q. (2026) · Journal of Sports Sciences · doi:10.1080/02640414.2026.2735681
“Karpe et al. (2011) also emphasized that the relationships among NEFA, insulin resistance, and metabolic health are complex and cannot be interpreted as a simple beneficial or adverse response (Karpe et al., 2011).”
Downie, C. G., Highland, H. M., Howard, A. G., Alotaibi, M., Elfassy, T., Cordero, C., Below, J. E., Carnethon, M. R., Cheng, S., Daviglus, M. L., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0360656
“The idea that insulin resistance, inflammation, and metabolic dysregulation are part of a “vicious cycle” [7] driven in part by increased free fatty acids levels in obesity is a prevailing model for T2D development [2,5,6].”
Metabolic heterogeneity of obesity
Smith, G. I., Petersen, M. C., Hartig, S. M., & Klein, S. (2026) · Nature Medicine · doi:10.1038/s41591-026-04718-7
Khan, R., Marsh, J. S., & Stewart, A. J. (2026) · Biomolecules · doi:10.3390/biom16111574
Jalbani, M. S., Naz, S., & Sidhu, A. R. (2026) · FRONTIERS IN CHEMICAL SCIENCES · doi:10.52700/fcs.v7i2.145
Black Elderberry Extract Reduces Cardiometabolic Risk by Lowering Inflammation in Mice
Farrell, N. J. (2015) · OpenCommons at University of Connecticut (University of Connecticut)
Metadata
- Authors
- Karpe, F., Dickmann, J. R., & Frayn, K. N.
- Affiliations
- John Radcliffe Hospital (GB)
- University of Oxford (GB)
- Corresponding author
- Karpe, Fredrik
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-09-16
- Volume
- 60
- Issue
- 10
- Pages
- 2441-2449
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3178283
- OpenAlex
- W2152688545
- Cited by
- 896
- References
- 91
- Citations by year
- 2026: 29 · 2025: 33 · 2024: 41 · 2023: 45 · 2022: 73 · 2021: 72 · 2020: 76 · 2019: 74 · 2018: 68 · 2017: 85 · 2016: 76 · 2015: 78 · 2014: 57 · 2013: 53 · 2012: 31
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- University of Oxford
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- free fatty acids, obesity, insulin resistance, adipose tissue lipolysis, fatty acid mobilization, plasma albumin binding, triacylglycerol mobilization, insulin signaling
- MeSH terms
- Adipose Tissue, Diabetes Mellitus, Fatty Acids, Nonesterified, Humans, Insulin Resistance, Obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.